Skip to Main Content

Paper Details

Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.
Cancer Res Commun
2
2022
BRCA1, BRCA1-proficient cell, BRCA1;p53-deficient mouse mammary tumor cells, BRCA1;p53-deficient tumors, DNA, LRRC8A, LRRC8D, Pt, cancers, carboplatin, cis- and carboplatin, cis- or car-boplatin, cisplatin, head and neck squamous cell carcinoma, mice, mouse, p53, patients, platinum
Author NameAffiliation
Colin C PritchardMouse Clinic for Cancer and Aging Research (MCCA), The Netherlands Cancer Institute
Wojciech FendlerMedical University of Lodz
Wojciech FendlerDana-Farber Cancer Institute
  • 1 - 3

Datasets

Release 1.2